120 related articles for article (PubMed ID: 8586759)
21. [Cuprum sulfate and vitix in the treatment of vitiligo in children].
Tsiskarishvili N
Georgian Med News; 2005 Apr; (121):48-51. PubMed ID: 15908724
[TBL] [Abstract][Full Text] [Related]
22. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
Hartmann A; Bröcker EB; Hamm H
J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
[TBL] [Abstract][Full Text] [Related]
23. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
Ortonne JP; MacDonald DM; Micoud A; Thivolet J
Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
[TBL] [Abstract][Full Text] [Related]
24. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
Nordlund JJ; Forget B; Kirkwood J; Lerner AB
Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
[TBL] [Abstract][Full Text] [Related]
25. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
26. Vitiligo: characterization of melanocytes in repigmented skin after punch grafting.
Kovacs D; Abdel-Raouf H; Al-Khayyat M; Abdel-Azeem E; Hanna MR; Cota C; Picardo M; Anbar TS
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):581-90. PubMed ID: 25089006
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation.
Cario-André M; Pain C; Gauthier Y; Casoli V; Taieb A
Pigment Cell Res; 2006 Oct; 19(5):434-42. PubMed ID: 16965272
[TBL] [Abstract][Full Text] [Related]
28. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.
Katayama I; Ashida M; Maeda A; Eishi K; Murota H; Bae SJ
Eur J Dermatol; 2003; 13(4):372-6. PubMed ID: 12948918
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
[TBL] [Abstract][Full Text] [Related]
30. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
Klahan S; Asawanonda P
Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
[No Abstract] [Full Text] [Related]
31. Baicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy.
Mir-Palomo S; Nácher A; Ofelia Vila Busó MA; Caddeo C; Manca ML; Manconi M; Díez-Sales O
Colloids Surf B Biointerfaces; 2019 Mar; 175():654-662. PubMed ID: 30590326
[TBL] [Abstract][Full Text] [Related]
32. Repigmentation of acrofacial vitiligo with subcutaneous tildrakizumab.
Jerjen R; Moodley A; Sinclair R
Australas J Dermatol; 2020 Nov; 61(4):e446-e448. PubMed ID: 32441048
[No Abstract] [Full Text] [Related]
33. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
[TBL] [Abstract][Full Text] [Related]
34. Translational Research in Vitiligo.
Katz EL; Harris JE
Front Immunol; 2021; 12():624517. PubMed ID: 33737930
[TBL] [Abstract][Full Text] [Related]
35. New and experimental treatments of vitiligo and other hypomelanoses.
Lotti T; Prignano F; Buggiani G
Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
[TBL] [Abstract][Full Text] [Related]
36. Topical methotrexate 1% gel for treatment of vitiligo: A case report and review of the literature.
Abdelmaksoud A; Dave DD; Lotti T; Vestita M
Dermatol Ther; 2019 Sep; 32(5):e13013. PubMed ID: 31265164
[TBL] [Abstract][Full Text] [Related]
37. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease.
Pasricha JS; Khaitan BK
Int J Dermatol; 1993 Oct; 32(10):753-7. PubMed ID: 8225724
[TBL] [Abstract][Full Text] [Related]
38. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
Lee AY; Kim NH; Choi WI; Youm YH
J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
[TBL] [Abstract][Full Text] [Related]
39. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.
Ameen M; Exarchou V; Chu AC
Br J Dermatol; 2001 Sep; 145(3):476-9. PubMed ID: 11531840
[TBL] [Abstract][Full Text] [Related]
40. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study.
Abdel Latif AA; Ibrahim SM
Dermatol Ther; 2015; 28(6):383-9. PubMed ID: 26358764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
